QUEBEC CITY, Feb. 19 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, David J. Mazzo, Ph.D., will present a company overview at the Roth Capital Partners 20th Annual OC Growth Stock Conference on February 20, 2008 at 4:00 pm PT, in the Ballroom of the Ritz Carlton Laguna Niguel in Dana Point, California.
A live webcast of this presentation will be available on AEterna Zentaris’ website at www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company’s website.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.
CONTACT: Jenene Thomas, Senior Director, Investor Relations & Corporate
Communications, (908) 626-5509, jthomas@aezsinc.com; Paul Burroughs, Media
Relations, (418) 652-8525, ext. 406, pburroughs@aezsinc.com
